Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Isung, J ^a   Aeinehband, S ^a   Mobarrez, F ^b   Martensson B ^a   Nordstrom P ^a   Asberg M ^b   Piehl, F ^a   Jokinen, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

cytokines; depression; interleukin 6; interleukin 8; suicide attempt; VEGF

Indexed keywords

CYTOKINE; INTERLEUKIN 8; VASCULOTROPIN; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 6; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOASSAY; INNATE IMMUNITY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PATHOPHYSIOLOGY; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; ADOLESCENT; AUTOMUTILATION; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870789626     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.123     Document Type: Article

References (34)

1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31. (Pubitemid 43083561)
2. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37: 137-162.
3. Kim Y-K, Lee S-W, Kim S-H, Shim S-H, Han S-W, Choi S-H et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 356-361. (Pubitemid 351178950)
4. Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008; 117: 198-206. (Pubitemid 351207982)
5. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009; 66: 287-292.
6. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-741.
7. Janelidze S, Mattei D, Westrin A°, Träskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011; 25: 335-339.
8. Jokinen J, Carlborg A, Ma° rtensson B, Forslund K, Nordström A-L, Nordström P. DST nonsuppression predicts suicide after attempted suicide. Psychiatry Res 2007; 150: 297-303.
9. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
10. Isung J, Mobarrez F, Nordström P, Asberg M, Jokinen J. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry 2012; 13: 468-473.
11. Tabachnick BG, Fidell LS. Using Multivariate Statistics. Pearson Allyn & Bacon, Boston, Mass; London: Pearson Education, 2007, p 980.
12. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009; 89: 607-648.
13. Nowacka MM, Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 2012; 46: 1-10.
14. Iacobaeus E, Amoudruz P, Ström M, Khademi M, Brundin L, Hillert J et al. The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis. PLoS ONE 2011; 6: e19138.
15. Warner-Schmidt JL, Duman RS. VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol 2008; 8: 14-19. (Pubitemid 351168696)
16. Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology 2009; 34: 2459-2468.
17. Sun R, Li N, Li T. VEGF regulates antidepressant effects of lamotrigine. Eur Neuropsychopharmacol 22: 424-430.
18. Segi-Nishida E. Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive seizure. Biol Pharm Bull 2011; 34: 939-944.
19. Elfving B, Wegener G. Electroconvulsive seizures stimulate the vegf pathway via mTORC1. Synapse 2012; 66: 340-345.
20. Kiuchi T, Lee H, Mikami T. Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice. Neuroscience 5: 208-217.
21. Heine VM, Zareno J, Maslam S, Joë ls M, Lucassen PJ. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci 2005; 21: 1304-1314. (Pubitemid 40516629)
22. Howell KR, Kutiyanawalla A, Pillai A. Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex. PLoS ONE 2011; 6: e20198.
23. Iga J-I, Ueno S-I, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 658-663. (Pubitemid 46476822)
24. Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L et al. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 2009; 34: 353-357.
25. Takebayashi M, Hashimoto R, Hisaoka K, Tsuchioka M, Kunugi H. Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J Neural Transm 2010; 117: 1119-1122.
26. Lee B-H, Kim Y-K. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord 2012; 136: 181-184.
27. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997; 90: 3322-3331. (Pubitemid 27473400)
28. Viikki M, Anttila S, Kampman O, Illi A, Huuhka M, Setä lä-Soikkeli E et al. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci Lett 2010; 477: 105-108.
29. Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ. Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 2010; 56: 1003-1008.
30. Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 2012; 122: 2454-2468.
31. Lehto SM, Niskanen L, Herzig K-H, Tolmunen T, Huotari A, Viinamä ki H et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010; 35: 226-232.
32. Uher T, Bob P. Cerebrospinal fluid IL-8 levels reflect symptoms of alexithymia in patients with non-inflammatory neurological disorders. Psychoneuroendocrinology 2011; 36: 1148-1153.
33. Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep 2011; 13: 467-475.
34. Raison CL, Miller AH. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry; e-pub ahead of print 31 January 2012; doi: 10. 1038/mp. 2012. 2.